298 related articles for article (PubMed ID: 32041669)
1. Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone injection and intravitreal dexamethasone implant: medical and economic importance of this randomized controlled trial.
Couret C; Poinas A; Volteau C; Riche VP; Le Lez ML; Errera MH; Creuzot-Garcher C; Baillif S; Kodjikian L; Ivan C; Le Jumeau de Kergaradec LM; Chiffoleau A; Jobert A; Jaulin J; Biron L; Hervouet E; Weber M
Trials; 2020 Feb; 21(1):159. PubMed ID: 32041669
[TBL] [Abstract][Full Text] [Related]
2. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
[TBL] [Abstract][Full Text] [Related]
4. [Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].
Bleriot A; Couret C; Le Meur G; Lebranchu P; Weber M
J Fr Ophtalmol; 2014 Oct; 37(8):599-604. PubMed ID: 25199486
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients.
Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y
Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512
[TBL] [Abstract][Full Text] [Related]
6. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial.
Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA;
Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924
[TBL] [Abstract][Full Text] [Related]
7. [Macular oedema and intravitreal triamcinolone injections].
Gunnlaugsdóttir E; Oehman DO; Gunnarsdóttir SG; Stefánsson E
Laeknabladid; 2006 Dec; 92(12):847-57. PubMed ID: 17206015
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
Sheth S; Rush R; Natarajan S; Gillies M
Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of macular edema: Comparison of efficacy and tolerability of subconjunctival triamcinolone injections, sub-tenon's triamcinolone injections and intravitreal dexamethasone implant].
Carbonnière C; Couret C; Blériot A; Lebreton O; Massé H; Le Meur G; Lebranchu P; Weber M
J Fr Ophtalmol; 2017 Mar; 40(3):177-186. PubMed ID: 28318718
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion.
Cheng KC; Wu WC; Chen KJ
Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of early injection of intravitreal triamcinolone acetonide (IVTA) versus delayed injection for macular edema resulting from retinal vein occlusion].
Saleh M; Gaucher D; Letsch J; Bourcier T; Speeg-Schatz C
J Fr Ophtalmol; 2011 Jun; 34(6):355-61. PubMed ID: 21652108
[TBL] [Abstract][Full Text] [Related]
12. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema.
Cardillo JA; Melo LA; Costa RA; Skaf M; Belfort R; Souza-Filho AA; Farah ME; Kuppermann BD
Ophthalmology; 2005 Sep; 112(9):1557-63. PubMed ID: 16019075
[TBL] [Abstract][Full Text] [Related]
13. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Jonas JB; Kreissig I; Kamppeter B; Degenring RF
Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
[TBL] [Abstract][Full Text] [Related]
14. Intracrystalline Ozurdex
Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema due to central retinal vein occlusion.
Wu WC; Cheng KC; Wu HJ
Eye (Lond); 2009 Dec; 23(12):2215-22. PubMed ID: 19218991
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of a Dexamethasone Implant for the Treatment of Refractory Cystoid Macular Oedema in Non-Infectious Uveitis].
Breitbach M; Rack D; Dietzel M; Heinz C; Heiligenhaus A
Klin Monbl Augenheilkd; 2016 May; 233(5):601-5. PubMed ID: 27187880
[TBL] [Abstract][Full Text] [Related]
18. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema.
Rahimi M; Shahrzad SS; Banifatemi M
Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
20. [The efficacy and safety of subconjunctival triamcinolone acetonide injections in treatment of uveitic macular edema].
Liu X; Wang M; Zhao C; Gao F; Zhang M
Zhonghua Yan Ke Za Zhi; 2015 Oct; 51(10):734-8. PubMed ID: 26693767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]